An over-expression of PRNP, unrelated to age, gender and stage, was initially reported in diverse types of solid cancers notably glioblastoma (GBM), pancreatic ductal adenocarcinoma (PDAC) and lung adenocarcinoma (LAC), CRC, GC and breast cancer (BC) [29, 30]. Here, PRNP is linked to glioblastoma.